Skip to main content

Advertisement

Log in

Effects of 10.6-μm laser moxibustion and electroacupuncture at ST36 in a 5-Fu-induced diarrhea rat model

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to investigate the effect of 10.6-μm laser moxibustion and electroacupuncture in 5-fluorouracil (5-Fu)-induced diarrhea model rats.

Methods

Forty-eight Sprague Dawley rats were randomly divided into 4 groups: a normal group, model group, 10.6-μm laser moxibustion (LM) group, and electroacupuncture (EA) group. Diarrhea was induced by 5-Fu (50 mg/kg) injection in 36 rats; the LM and EA groups received treatment at acupoint ST36 (Zusanli) on hind limbs once a day for 6 days.

Results

5-Fu injection caused body weight decline and diarrhea. From the 5th to 7th day, the LM group showed higher body weights than the model group (P < 0.05). On the 6th day, diarrhea score of the LM group was better than that of the EA group (P < 0.05). Both scores of the LM group and EA group were better than that of model group (P < 0.05). The LM group and EA group both had better intestine pathological scores and lower endotoxin (ET) and diamine oxide (DAO) activity than the model group (P < 0.01). The LM group got better pathological scores than the EA group (P < 0.01). Ultramicroscopic structures of the model group showed severe damage while the LM group and EA group remained good in their small intestines. The model group had obviously decreased occludin protein in intestine tissues than the control group (P < 0.01), while occludin expressions in the LM group and EA group were both obviously increased compared with the model group (P < 0.01).

Conclusion

LM and EA treatment on ST36 could alleviate damage to intestinal barrier function and alleviate diarrhea caused by 5-Fu.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Arbuckle RB, Huber SL, Zacker C (2000) The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist 5(3):250–259

    CAS  PubMed  Google Scholar 

  2. Arnold RJ, Gabrail N, Raut M, Kim R, Sung JC, Zhou Y (2005) Clinical implications of chemotherapy-induced diarrhea in patients with cancer. J Support Oncol 3(3):227–232

    PubMed  Google Scholar 

  3. Richardson G, Dobish R (2007) Chemotherapy induced diarrhea. J Oncol Pharm Pract 13(4):181–198

    CAS  PubMed  Google Scholar 

  4. Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330–338

    CAS  PubMed  Google Scholar 

  5. Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 206:107447

    CAS  PubMed  Google Scholar 

  6. Mitchell EP (2006) Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 33(1):106–120

    CAS  PubMed  Google Scholar 

  7. McQuade RM, Stojanovska V, Donald E, Abalo R, Bornstein JC, Nurgali K (2016) Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil. Neurogastroenterol Motil 28(12):1861–1875

    CAS  PubMed  Google Scholar 

  8. Stein A, Voigt W, Jordan K (2010) Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2(1):51–63

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95(1):155–163

    PubMed  Google Scholar 

  10. Lee SH, Son MH, Sung KW, Choi YB, Lee NH, Yoo KH, Koo HH, Lim DH, Shin HJ (2014) Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults. J Neuro-Oncol 120(3):507–513

    CAS  Google Scholar 

  11. Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, Wedlake L, Bridgewater J, Glynne-Jones R, Allum W, Chau I, Wilson R, Ferry D (2014) Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol 15(10):e447–e460

    PubMed  Google Scholar 

  12. Bowen JM, Gibson RJ, Keefe DM (2014) Animal models of mucositis: implications for therapy. J Support Oncol 9(5):161–168

    Google Scholar 

  13. Lalla RV (2015) Alleviating mucositis: are we on track for a novel therapeutic? Expert Rev Gastroenterol Hepatol 9(2):127–128

    CAS  PubMed  Google Scholar 

  14. Wei D, Heus P, van de Wetering FT, van Tienhoven G, Verleye L, Scholten RJ (2018) Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhea in people with cancer. Cochrane Database Syst Rev 8(8):CD008831

    PubMed  Google Scholar 

  15. McQuade RM, Stojanovska V, Abalo R, Bornstein JC, Nurgali K (2016) Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments. Front Pharmacol 7:414

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Wu Q, Chen B, Yan G, Yang Z, Xiong L, He J (2018) A systematic review and meta-analysis of gastrointestinal events associated with nonoperative therapies for neuroendocrine tumors. Onco Targets Ther 11:7655–7668

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Chu D, Cheng P, Xiong H, Zhang J, Liu S, Hou X (2011) Electroacupuncture at ST-36 relieves visceral hypersensitivity and decreases 5-HT (3) receptor level in the colon in chronic visceral hypersensitivity rats. Int J Color Dis 26(5):569–574

    Google Scholar 

  18. Chen Y, Zhao Y, Luo DN, Zheng H, Li Y, Zhou SY (2019) Electroacupuncture regulates disorders of gut-brain interaction by decreasing corticotropin-releasing factor in a rat model of IBS. Gastroenterol Res Pract 2019:1759842

    PubMed  PubMed Central  Google Scholar 

  19. Zhu X, Liu Z, Niu W, Wang Y, Zhang A, Qu H, Zhou J, Bai L, Yang Y, Li J (2017) Effects of electroacupuncture at ST25 and BL25 in a Sennae-induced rat model of diarrhoea-predominant irritable bowel syndrome. Acupunct Med 35(3):216–223

    PubMed  Google Scholar 

  20. Zhang HW, Lin ZX, Cheung F, Cho WC, Tang JL (2018) Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer. Cochrane Database Syst Rev 11(11):CD010559

    PubMed  Google Scholar 

  21. Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG (2017) Effects of herb-partitioned moxibustion on the miRNA expression profiles in colon from rats with DSS induced ulcerative colitis. Evid Based Complement Alternat Med 2017:1767301

    PubMed  PubMed Central  Google Scholar 

  22. Tang B, Zhang J, Yang Z, Lu Y, Xu Q, Chen X, Lin J (2016) Moxibustion for diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2016:5105108

    PubMed  PubMed Central  Google Scholar 

  23. Huang SM, Chien LY, Tai CJ, Chen PH, Lien PJ, Tai CJ (2015) Effects of symptoms and complementary and alternative medicine use on the yang deficiency pattern among breast cancer patients receiving chemotherapy. Complement Ther Med 23(2):233–241

    PubMed  Google Scholar 

  24. Shen X, Ding G, Wei J, Zhao L, Zhou Y, Deng H, Lao L (2006) An infrared radiation study of the biophysical characteristics of traditional moxibustion. Complement Ther Med 14(3):213–219

    PubMed  Google Scholar 

  25. Zhao L, Shen X (2012) Chemical and physical characteristics of moxibustion. In: Xia Y, Ding G, Wu GC (eds) Current Research in Acupuncture. Springer, Heidelberg, pp 109–127

    Google Scholar 

  26. Mao H, Mao JJ, Guo M, Cheng K, Wei J, Shen X, Shen X (2016) Effects of infrared laser moxibustion on cancer-related fatigue: a randomized, double-blind, placebo-controlled trial. Cancer 122(23):3667–3672

    PubMed  PubMed Central  Google Scholar 

  27. Kato S, Hayashi S, Kitahara Y, Nagasawa K, Aono H, Shibata J, Utsumi D, Amagase K, Kadowaki M (2015) Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells. PLoS One 10(1):e0116213

    PubMed  PubMed Central  Google Scholar 

  28. Sangild PT, Shen RL, Pontoppidan P, Rathe M (2018) Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 314(2):G231–G246

    PubMed  Google Scholar 

  29. Trifan OC, Durham WF, Salazar VS, Horton J, Levine BD, Zweifel BS, Davis TW, Masferrer JL (2002) Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. Cancer Res 62(20):5778–5784

    CAS  PubMed  Google Scholar 

  30. Kurita A, Kado S, Kaneda N, Onoue M, Hashimoto S, Yokokura T (2000) Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats. Cancer Chemother Pharmacol 46:211–220

    CAS  PubMed  Google Scholar 

  31. Yu S, Xu B (2012) Experimental acupuncture and moxibustion [M]. People’s Health Publishing House, Beijing, p 270

    Google Scholar 

  32. Zhao L, Shen XY, Gao JP, Ding GH, Wei JZ, Deng HP, Wang L, Zhao XY (2006) Effect of different LLLT on pituitrin induced bradycardia in the rabbit [J]. Lasers Med Sci 21(2):61–66

    PubMed  Google Scholar 

  33. Xiao L, Cui T, Liu S, Chen B, Wang Y, Yang T, Li T, Chen J (2019) Vitamin A supplementation improves the intestinal mucosal barrier and facilitates the expression of tight junction proteins in rats with diarrhea. Nutrition 57:97–108

    CAS  PubMed  Google Scholar 

  34. Miyoshi J, Miyamoto H, Goji T, Taniguchi T, Tomonari T, Sogabe M, Kimura T, Kitamura S, Okamoto K, Fujino Y, Muguruma N, Okahisa T, Takayama T (2015) Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs. J Gastroenterol Hepatol 30(11):1582–1590

    CAS  PubMed  Google Scholar 

  35. Ye YJ, Lu YS, Zhou X, Chen HY, Xue SY, Kuai L (2016) Protective effects of acupuncture intervention against damage of intestinal mucosal barrier induced by 5-fluorouracil in rats. Zhen Ci Yan Jiu 41(2):95–99 (In Chinese)

    PubMed  Google Scholar 

  36. Ali J, Khan AU, Shah FA, Ali H, Islam SU, Kim YS, Khan S (2019) Mucoprotective effects of saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. Life Sci 239:116888

    CAS  PubMed  Google Scholar 

  37. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11(12):4131–4142

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Keren DF (1988) Intestinal mucosal immune defense mechanisms. Am J Surg Pathol 12(Suppl 1):100–105

    PubMed  Google Scholar 

  39. Mantis NJ, Rol N, Corthésy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4(6):603–611

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, Watkins SC, Ford HR (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92(1):71–77

    CAS  PubMed  Google Scholar 

  41. Zhou C, Zhao J, Wu L, Huang R, Shi Y, Wang X, Liao W, Hong J, Liu S, Wu H (2014) Mild moxibustion decreases the expression of prokineticin 2 and prokineticin receptor 2 in the colon and spinal cord of rats with irritable bowel syndrome. Evid Based Complement Alternat Med 2014:807308

    PubMed  PubMed Central  Google Scholar 

  42. Zhou SL, Zhang XL, Wang JH (2017) Comparison of electroacupuncture and medical treatment for functional constipation: a systematic review and meta-analysis. Acupunct Med 35(5):324–331

    PubMed  Google Scholar 

  43. Zhu X, Liu Z, Qu H, Niu W, Gao L, Wang Y, Zhang A, Bai L (2016) The effect and mechanism of electroacupuncture at LI11 and ST37 on constipation in a rat model. Acupunct Med 34(3):194–200

    PubMed  Google Scholar 

  44. Zou W, Lin H, Liu W, Yang B, Wu L, Duan L, Ling P, Zhu L, Dai Q, Zhao L, Zou T, Zhang D (2016) Moxibustion relieves visceral hyperalgesia via inhibition of transient receptor potential vanilloid 1 (TRPV1) and heat shock protein (HSP) 70 expression in rat bone marrow cells. Acupunct Med 34(2):114–119

    PubMed  Google Scholar 

  45. Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N (2012) Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol 25(2):106–118

    PubMed  PubMed Central  Google Scholar 

  46. Wisinski K, Benson A 3rd (2007) Chemotherapy-induced mucositis: focusing on diarrhea. J Support Oncol 5(6):270–271

    CAS  PubMed  Google Scholar 

  47. Saltz LB (2006) Managing chemotherapy-induced diarrhea. Clin Adv Hematol Oncol 4(3):203–204

    PubMed  Google Scholar 

  48. Rafiee-Tehrani M, Verhoef JC, Junginger HE (2004) Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers. J Pharm Sci 93(3):743–752

    PubMed  Google Scholar 

  49. Wong YC (2016) Need of integrated dietary therapy for persons with diabetes mellitus and “unhealthy” body constitution presentations. J Integr Med 14(4):255–268

    PubMed  Google Scholar 

  50. Leong PK, Wong HS, Chen J, Ko KM (2015) Yang/Qi invigoration: an herbal therapy for chronic fatigue syndrome with yang deficiency? Evid Based Complement Alternat Med 2015:945901

    PubMed  PubMed Central  Google Scholar 

  51. Zhu J, Liu S, Guo Y, Hou L, Su X, Li Y, Han B, Liu D, Wang Q, Chen JJ, Wei W (2018) A new model of diarrhea with spleen-kidney yang deficiency syndrome. Evid Based Complement Alternat Med 2018:4280343

    PubMed  PubMed Central  Google Scholar 

  52. Guo Q, Yao C, Guo YF, Wang M (2000) Clinical efficacy and action mechanism of mild moxibustion combined with salt-separated moxibustion for gastrointestinal response in breast-cancer chemotherapy patients. Zhongguo Zhen Jiu 40(1):8–12 Chinese

    Google Scholar 

  53. Ying J, Gou CY (2015) Clinical observation of suspended moxibustion on delayed diarrhea due to chemotherapy regimen containing irinotecan. J Emerg Trad Chin Med 024:794–796

    Google Scholar 

  54. Deng H, Shen X (2013) The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med 2013:379291

    PubMed  PubMed Central  Google Scholar 

  55. Omi T, Numano K (2014) The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther 23(1):49–60

    PubMed  PubMed Central  Google Scholar 

  56. Zhu L, Ma Y, Ye S, Shu Z (2018) Acupuncture for diarrhoea-predominant irritable bowel syndrome: a network meta-analysis. Evid Based Complement Alternat Med 2018:2890465

    PubMed  PubMed Central  Google Scholar 

  57. Wang C, Chen X, Xie PY (2014) Electroacupuncture at PC6 or ST36 influences the effect of tacrine on the motility of esophagus. Evid Based Complement Alternat Med 2014:263489

    PubMed  PubMed Central  Google Scholar 

  58. Iwa M, Matsushima M, Nakade Y, Pappas TN, Fujimiya M, Takahashi T (2006) Electroacupuncture at ST-36 accelerates colonic motility and transit in freely moving conscious rats. Am J Physiol Gastrointest Liver Physiol 290(2):G285–G292

    CAS  PubMed  Google Scholar 

  59. Yu Z (2020) Neuromechanism of acupuncture regulating gastrointestinal motility. World J Gastroenterol 26(23):3182–3200

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the National Natural Science Foundation of China (81874506).

Author information

Authors and Affiliations

Authors

Contributions

Prof. Xueyong Shen had full access to all study data and take responsibility for the integrity of the data and the accuracy of the data analysis. Huaijin Cheng and Ling Zhao contributed equally to this manuscript.

Concept and design: X. Shen.

Acquisition, analysis, or interpretation of data: L. Zhao, H. Cheng, Z. Ju, F. Wang, M. Qin, and H. Mao.

Critical revision of the manuscript for important intellectual content: all authors.

Corresponding author

Correspondence to Xueyong Shen.

Ethics declarations

The Committee on the Ethics of Animal Experiments of Shanghai University of Traditional Chinese Medicine approved all animal studies and procedures (approval ID: 201610009), and all studies were conducted in accordance with the National Institutes for Health (NIH) “Guide for the Care and Use of Laboratory Animals” to reduce pain and to avoid harm.

Conflict of interest

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 23 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, H., Zhao, L., Ju, Z. et al. Effects of 10.6-μm laser moxibustion and electroacupuncture at ST36 in a 5-Fu-induced diarrhea rat model. Support Care Cancer 29, 2561–2569 (2021). https://doi.org/10.1007/s00520-020-05788-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05788-0

Keywords

Navigation